12th International Conference and Exhibition on
Pharmacovigilance & Drug Safety
Theme: Exploring Latest Trends in Pharmacovigilance and Clinical Trials
Conference Brochure | Submit Abstract | Scientific Sessions
Conference series takes pleasure in inviting the scientific community across the globe to attend the 12th International Conference and Exhibition on Pharmacovigilance & Drug Safety during July 04-05, 2019 at Valencia, Spain with a motto to Exploring Latest Trends in Pharmacovigilance and Clinical Trials.
The gathering will address sustainable developments in the area of Pharmacovigilance and Drug Safety, while laying emphasis on innovative methodologies in Medical Sciences and Pharmaceuticals. Pharmacovigilance 2019 will be the best venue for academicians, researchers and interested parties to discuss proposals and advancements in Pharmacovigilance, Risk Management, and Drug Safety.
The organizing committee including eminent scholars and researchers such as Ashok Srivastava, CEO, Cure Pharmaceuticals and ClinFomatrix Oncology, USA, Paola Antonini, MD, University of Rome, Italy, Mircea Ciuca, MD, Global Head of Medical & Clinical Drug Safety at Vifor Pharma, Switzerland, Heyam Saad Ali, Professor, Dubai Pharmacy College, United Arab Emirates, Robert L. Barkin, Professor, Department of Anesthesiology & Pharmacology, USA have finalized a very attractive and promising sessions during Pharmacovigilance and Drug Safety 2019 to promote meaningful discussion.
Pharmacovigilance 2019 Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. The ‘Best Poster Award’ is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase.
The important tracks that are part of Pharmacovigilance 2019 includes: Pre-Clinical and Clinical Trials, Adverse Drug Reactions, Pharmacovigilance and Risk Management, Pharmacy Practices and its Challenges, Clinical Trials on Various Disorders, Data Quality, Management and Analysis, Pharmacovigilance Significance & Scope, Diversity in Industrial Clinical Trials and Clinical Research, Clinical Research and Statistics, Case Report in Clinical Trials, Drug Safety, Clinical Data Base Management, PV Consulting’s and Business opportunity, Entrepreneurs Investment Meet
Pharmacovigilance 2019 is comprised of 17 tracks and 81 sessions designed to offer comprehensive sessions that address current issue. For more scientific sessions and abstract submission, please visit:
The Abstracts that are accepted for presentation are published in the proceedings of the Journals like Journal of Pharmacovigilance, Journal of Clinical & Experimental Pharmacology and Journal of Clinical Trials.
Grab the opportunity to participate by registering through flowing link:
For further details, please contact:
Program Manager |
47 Churchfield Road
London, W3 6AY, UK